Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)

NCT00321854 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

535

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: pramipexole

Sponsor

Boehringer Ingelheim